Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Nanosonics Limited ( (AU:NAN) ) is now available.
UBS Group AG and its related bodies corporate have ceased to be substantial shareholders in Nanosonics Limited as of June 24, 2025. This change in shareholding may impact Nanosonics’ market perception and stakeholder confidence, as substantial shareholders often play a crucial role in influencing company strategy and investor sentiment.
The most recent analyst rating on (AU:NAN) stock is a Sell with a A$4.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, specializing in infection control solutions. The company is known for its innovative products that focus on preventing healthcare-associated infections, with a significant market presence in the medical technology sector.
Average Trading Volume: 987,689
Technical Sentiment Signal: Buy
Current Market Cap: A$1.23B
For an in-depth examination of NAN stock, go to TipRanks’ Overview page.